Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Offer Mixed Price Targets for Frontline NYSEFRO

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finance_Financing
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

On March 2, 2024, analyst Samuel Bland of JP Morgan reaffirmed a Neutral rating on Frontline (NYSE:FRO) but adjusted the price target to $22.3.
_____
Various analysts have offered different price targets for Frontline, averaging at $23.32.
_____
As of October 4, 2023, the average one-year price target for Frontline stood at $22.95, with estimates ranging from $16.16 to $35.70.

Frontline Ltd. (FRO) Stock Shows Strong Performance on March 2, 2024: A Sign of Future Growth Potential

On March 2, 2024, Frontline Ltd. (FRO) had a strong performance in the stock market. FRO was trading near the top of its 52-week range and above its 200-day simple moving average, indicating that the stock has been performing well in the long term and is currently in an uptrend.

The price of FRO shares increased by $0.05 since the market last closed, representing a 0.22% rise. The stock closed at $22.58, showing a positive movement in the stock price. Additionally, in after-hours trading, the stock continued to rise by $0.02, further demonstrating investor confidence in the company.

Frontline Ltd. is a shipping company that specializes in the transportation of crude oil and petroleum products. As global demand for oil continues to rise, companies like Frontline Ltd. stand to benefit from increased shipping volumes. The positive stock performance on March 2, 2024, reflects investor optimism in the company’s future prospects.

Investors should continue to monitor FRO’s performance in the coming days to see if the positive momentum continues. Frontline Ltd. has shown strength in its stock performance, and investors may want to keep an eye on this company for potential investment opportunities.

FRO Stock Shows Strong Financial Performance with Significant Revenue and Income Growth in 2024

On March 2, 2024, FRO stock showed promising performances as the company reported strong financial results. According to data from CNN Money, FRO’s total revenue for the past year was $1.80 billion, marking a 27.12% increase compared to the previous year. Similarly, FRO’s net income also demonstrated significant growth, with a total of $656.41 million for the past year, reflecting a 38.04% increase from the previous year. Earnings per share (EPS) for FRO also showed positive growth, with a total of $2.95 for the past year, representing a 32.7% increase from the previous year. Overall, FRO’s financial performance on March 2, 2024, indicates a strong and stable growth trajectory. Investors may view these results as a positive indicator of the company’s financial health and future potential.

Tags: FRO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Information Technology Stock Market Today

Analysts Provide Mixed Ratings and Price Targets for Shoals Technologies Group

Beverages Industry Markets and money (1)

PepsiCo Unveils New Global Logo Redesign and Financial Updates

COST stock news

Analyst Kenneth Wong Bullish on Autodesk Raises Price Target to 315

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com